Cargando…
Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study
OBJECTIVE: The need of luteal support after FET is no longer to be proven. Different routes of progesterone administration are available with interindividual differences in metabolization and serum progesterone levels, the latter being highly correlated with pregnancy and delivery rates. The adminis...
Autores principales: | Simon, Virginie, Robin, Geoffroy, Keller, Laura, Ternynck, Camille, Jonard, Sophie, Robin, Camille, Decanter, Christine, Plouvier, Pauline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822263/ https://www.ncbi.nlm.nih.gov/pubmed/36619564 http://dx.doi.org/10.3389/fendo.2022.1039579 |
Ejemplares similares
-
Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?
por: Netter, Antoine, et al.
Publicado: (2019) -
Serum progesterone level in luteal phase improves pregnancy rate in
fresh cycles with blastocyst embryo transfer
por: Scheffer, Juliano Brum, et al.
Publicado: (2023) -
Addition of intramuscular to vaginal progesterone for luteal phase support in fresh embryo transfer cycles: A cross-sectional study
por: Jalaliani, Samaneh, et al.
Publicado: (2022) -
The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
por: Toriumi, Rena, et al.
Publicado: (2023) -
The Future of Luteal Phase Support in ART and the Role of Dydrogesterone
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)